Collaboration in diagnostics

Worldwide partnering expands innovation network in the area of in vitro diagnostics. The division harnesses both internally- and externally-generated innovation through licensing deals, partnerships and collaboration on both a scientific and commercial basis. These alliances and networks span the globe to help assure that Roche gains access to the most important emerging technologies, where ever they may be.

The Division’s Chief Technology Office evaluates new technologies annually and monitors

• academia,
• biotech start-ups,
• spin-offs from universities,
• small and large companies as well as
• service and government laboratories around the world.

The goal is to identify those technologies which complement Roche’s existing portfolio, helping to secure its future product pipeline. By monitoring and cooperating with diverse sources of knowledge and technologies from disciplines such as biochemistry, molecular biology, physics, engineering and informatics, Roche is able to tap into a large pool of creative and unconventional ideas and discoveries, increasing its chances to successfully advance projects from its research labs to the marketplace.